That could be I was looking at the second to last line on

Celltrion's ZYMFENTRA® Demonstrates Efficacy in Crohn's Disease Celltrion, Inc. has recently published promising results from a post-hoc analysis of the LIBERTY-CD study regarding ZYMFENTRA® (infliximab-dyyb). This analysis reveals significant findings about the efficacy of ZYMFENTRA in treating Crohn's disease (CD), regardless of disease location, and it's exciting...

Akamai Cloud Achieves FedRAMP High Ready Status CAMBRIDGE, Mass. – Akamai Technologies, Inc. (NASDAQ: AKAM), a leader in cybersecurity and cloud computing, has proudly announced its recent achievement of the FedRAMP High Ready status. This vital milestone confirms that Akamai is fully prepared to offer federal agencies cloud services that comply with the most rigorous...

Sam Bankman-Fried's Explosive Revelations About FTX In a recently penned letter, former FTX founder Sam Bankman-Fried expressed a firm belief that FTX was never truly insolvent. He attributed much of the downfall of what he called a "$136 billion enterprise" to mismanagement by attorneys, laying blame for the financial struggles on those who were supposed to provide legal...

Kraus Hamdani Aerospace's K1000ULE Achieves Remarkable Milestone Kraus Hamdani Aerospace, an innovator in autonomy and AI-driven unmanned systems, has announced the inclusion of its K1000ULE UAS in the U.S. Department of Defense's trusted Blue UAS Cleared List and Select List. This recognition marks a significant achievement in the field of unmanned aerial vehicles,...

Understanding the Vendor Neutral Archive (VNA) & PACS Market Growth The Vendor Neutral Archive (VNA) and Picture Archiving and Communication System (PACS) market is entering an exciting growth phase. This market, valued at approximately US$4.62 billion recently, is predicted to experience a significant uptick as it is forecasted to expand at a remarkable compound annual...